Induced pluripotent stem cells and Parkinson's disease: modelling and treatment

被引：14
|
作者：
Xu, Xiaoyun [1 ]
Huang, Jinsha [1 ]
Li, Jie [1 ]
Liu, Ling [1 ]
Han, Chao [1 ]
Shen, Yan [1 ]
Zhang, Guoxin [1 ]
Jiang, Haiyang [1 ]
Lin, Zhicheng [2 ]
Xiong, Nian [1 ]
Wang, Tao [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Hubei, Peoples R China
[2] Harvard Univ, McLean Hosp, Mailman Neurosci Res Ctr, Dept Psychiat,Med Sch,Div Alcohol & Drug Abuse, Belmont, MA 02178 USA
来源：
CELL PROLIFERATION | 2016年 / 49卷 / 01期
基金：
中国国家自然科学基金;
关键词：
MIDBRAIN DOPAMINERGIC-NEURONS; IPSC-DERIVED NEURONS; PRIMATE MODEL; HIGHLY EFFICIENT; RAT MODEL; NEURAL PRECURSORS; OXIDATIVE STRESS; IN-VITRO; GENERATION; DIFFERENTIATION;
D O I：
10.1111/cpr.12229
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Many neurodegenerative disorders, such as Parkinson's disease (PD), are characterized by progressive neuronal loss in different regions of the central nervous system, contributing to brain dysfunction in the relevant patients. Stem cell therapy holds great promise for PD patients, including with foetal ventral mesencephalic cells, human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Moreover, stem cells can be used to model neurodegenerative diseases in order to screen potential medication and explore their mechanisms of disease. However, related ethical issues, immunological rejection and lack of canonical grafting protocols limit common clinical use of stem cells. iPSCs, derived from reprogrammed somatic cells, provide new hope for cell replacement therapy. In this review, recent development in stem cell treatment for PD, using hiPSCs, as well as the potential value of hiPSCs in modelling for PD, have been summarized for application of iPSCs technology to clinical translation for PD treatment.
引用
收藏
页码：14 / 26
页数：13
相关论文
共 50 条
  • [1] Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson's Disease
    Lebedeva, O. S.
    Lagarkova, M. A.
    BIOCHEMISTRY-MOSCOW, 2018, 83 (09) : 1046 - 1056
  • [2] Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson’s Disease
    O. S. Lebedeva
    M. A. Lagarkova
    Biochemistry (Moscow), 2018, 83 : 1046 - 1056
  • [3] Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells
    Stoddard-Bennett, Theo
    Pera, Renee Reijo
    CELLS, 2019, 8 (01)
  • [4] From cell lines to pluripotent stem cells for modelling Parkinson's Disease
    Ferrari, Elena
    Cardinale, Antonella
    Picconi, Barbara
    Gardoni, Fabrizio
    JOURNAL OF NEUROSCIENCE METHODS, 2020, 340
  • [5] Cell therapy for Parkinson's disease with induced pluripotent stem cells
    Morizane, A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A16 - A16
  • [6] The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
    Kang, Ji-feng
    Tang, Bei-sha
    Guo, Ji-feng
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [7] Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
    Blake Byers
    Hsiao-lu Lee
    Renee Reijo Pera
    Current Neurology and Neuroscience Reports, 2012, 12 : 237 - 242
  • [8] Modeling Parkinson's Disease Using Induced Pluripotent Stem Cells
    Byers, Blake
    Lee, Hsiao-lu
    Pera, Renee Reijo
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (03) : 237 - 242
  • [9] Using induced pluripotent stem cells for modeling Parkinson's disease
    Ke, Minjing
    Chong, Cheong-Meng
    Su, Huanxing
    WORLD JOURNAL OF STEM CELLS, 2019, 11 (09): : 634 - 649
  • [10] Cell therapy for Parkinson’s disease with induced pluripotent stem cells
    Asuka Morizane
    Inflammation and Regeneration, 43
12345